Handheld Minimally Invasive Surgical Instruments Market Size
The global handheld minimally invasive surgical instruments market size reached US$ 31.69 Billion in 2024 and is expected to reach US$ 71.91 Billion by 2033, growing at a CAGR of 9.6% during the forecast period 2025-2033.
Handheld Minimally Invasive Surgical Instruments Market Overview
The handheld minimally invasive surgical instruments market is poised for continued growth, driven by technological innovations, increasing demand for minimally invasive procedures, and a rising global burden of chronic diseases. Emerging markets, particularly in the Asia-Pacific region, present significant opportunities for expansion. However, addressing challenges such as high instrument costs and navigating stringent regulatory landscapes will be crucial for sustained market growth. Key players are focusing on strategic partnerships, product approvals, and launches to gain market share. The major manufacturers include Stryker and Medtronic, investing heavily in R&D and geographic expansion.
Handheld Minimally Invasive Surgical Instruments Market Executive Summary
Handheld Minimally Invasive Surgical Instruments Market Dynamics: Drivers & Restraints
The rising demand for minimally invasive surgeries is significantly driving the handheld minimally invasive surgical instruments market growth
Minimally invasive surgeries have gained immense popularity due to their numerous benefits over traditional open surgeries, such as reduced patient trauma, shorter hospital stays, faster recovery times, and lower infection risks. This rising preference is a key factor propelling the growth of the handheld minimally invasive surgical instruments market. For instance, according to the Government of Saskatchewan, more than 95,700 surgeries were performed between April 1, 2023, and March 31, 2024, the highest annual surgical volume ever recorded. These rising surgeries are propelling the market growth.
According to the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS), 83 percent of the total number of procedures performed in 2023 were minimally invasive. Additionally, according to the procedures at the ISAPS World Congress in Cartagena, there is a higher increase of 5.5% in surgical procedures, with more than 15.8 million procedures performed by plastic surgeons. Over the last four years, the overall increase is 40%. This increasing number of surgeries and minimally invasive surgeries is driving the growth of handheld minimally invasive surgical instruments.
The high cost of instruments and technologies is hampering the growth of the market
Many handheld instruments used in minimally invasive procedures, such as laparoscopic scissors, endoscopic forceps, and robotic-assisted tools, come with high upfront costs. These tools often feature advanced materials, precision engineering, and specialized functionalities, all of which contribute to their high price. For instance, according to ScienceDirect, direct instrument costs for handheld robotic devices in general surgery were $310 vs $973 when comparing HandX with the DaVinci, respectively.
Many handheld instruments are used alongside imaging technologies, such as laparoscopes and endoscopes, which provide real-time visualization. While these technologies improve surgical precision, they also come with high costs. For instance, a high-definition endoscopic system can cost between $25,000 and $50,000, while advanced systems integrated with 3D imaging or real-time data processing can push costs even higher.
For more details on this report – Request for Sample
Handheld Minimally Invasive Surgical Instruments Market, Segment Analysis
The global handheld minimally invasive surgical instruments market is segmented based on product type, application, end-user, and region.
Laparoscopy from the application segment is expected to hold 31.52% of the market share in 2024 in the handheld minimally invasive surgical instruments market
Laparoscopy is extensively used in general surgery, gynecology, urology, and bariatric procedures. The versatility of laparoscopic instruments, such as graspers, scissors, and dissectors, supports a broad spectrum of minimally invasive surgeries. Globally, laparoscopic surgeries have become the standard of care for many abdominal and pelvic conditions. For instance, 13 million laparoscopic surgeries are conducted annually. These rising laparoscopic surgeries are boosting the demand for handheld minimally invasive surgical instruments, which is accelerating the segment growth.
Laparoscopy has become the gold standard for many types of minimally invasive surgeries because it offers faster recovery times, less postoperative pain, and smaller scars. These advantages are particularly appealing to patients, leading to the growing preference for laparoscopic techniques. For instance, HandX is a lightweight, FDA-cleared, and CE-marked device that combines the benefits of robotics and handheld instruments. HandX allows the surgeon to perform complex minimally invasive surgeries using a device that combines the benefits of a surgical robotic-based platform with the simplicity and affordability of traditional laparoscopic surgery.
Handheld Minimally Invasive Surgical Instruments Market, Geographical Analysis
North America is expected to dominate the global handheld minimally invasive surgical instruments market with a 42.98% share in 2024
Many global manufacturers of handheld surgical instruments, such as Medtronic, Stryker, Johnson & Johnson, and other emerging players, are headquartered or have significant operations in North America, driving innovation and market penetration. For instance, in October 2024, LivsMed, a leader in minimally invasive surgical devices, released ArtiSential 5, the first 5mm wristed articulating laparoscopic instrument series on the market. ArtiSential 5 represents a dramatic expansion of the company’s acclaimed ArtiSential line, offering enhanced flexibility and ease of use.
Specialized centers for procedures such as cardiac surgery, bariatric surgery, orthopedic surgery, and gastrointestinal surgeries often use advanced handheld minimally invasive instruments, further driving demand in the region. A report by IBISWorld indicated that the U.S. healthcare sector was valued at approximately $4.8 trillion in 2023, with a significant portion allocated to surgical services and procedures that use minimally invasive techniques.
Asia-Pacific is growing at the fastest pace in the handheld minimally invasive surgical instruments market, holding 20.03% of the market share
The large and aging population, coupled with rising incidences of chronic diseases like cancer and cardiovascular conditions, is driving demand for surgical interventions. For instance, India and China are witnessing exponential growth in laparoscopic and other minimally invasive surgical procedures. Governments are supporting healthcare reforms and funding to improve surgical care accessibility. Additionally, foreign medical device companies are entering APAC markets through partnerships and local manufacturing to meet rising demand.
Thailand, India, and Singapore are becoming global hubs for affordable, high-quality minimally invasive surgeries, increasing the demand for handheld surgical tools. Countries like China, India, and Southeast Asian nations are heavily investing in upgrading hospital facilities and surgical capabilities, which is increasing access to minimally invasive procedures. For instance, Apollo Hospitals in India has reported a steady increase in laparoscopic and robotic-assisted procedures, supported by increased demand for handheld instruments like laparoscopic scissors, graspers, and trocars.
Handheld Minimally Invasive Surgical Instruments Market Competitive Landscape
Top companies in the handheld minimally invasive surgical instruments market include Medtronic plc, Olympus Corporation, Stryker Corporation, Meril Life Sciences Pvt. Ltd., Boston Scientific Corporation, Wexler Surgical, CONMED Corporation, Smith+Nephew, CooperSurgical Inc., and Johnson & Johnson, among others.
Handheld Minimally Invasive Surgical Instruments Market Scope
Metrics | Details | |
CAGR | 9.6% | |
Market Size Available for Years | 2022-2033 | |
Estimation Forecast Period | 2025-2033 | |
Revenue Units | Value (US$ Bn) | |
Segments Covered | Product Type | Graspers and Forceps, Needle Holders, Scalpels and Dissection Instruments, Retractors, Scissors, Others |
Application | Laparoscopy, Arthroscopy, Endoscopy, others | |
End-User | Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Other | |
Regions Covered | North America, Europe, Asia-Pacific, South America, and the Middle East & Africa | |
The global handheld minimally invasive surgical instruments market report delivers a detailed analysis with 62 key tables, more than 57 visually impactful figures, and 175 pages of expert insights, providing a complete view of the market landscape.
